STOCKHOLM, Aug. 8, 2025 /PRNewswire/ -- SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3) Net sales amounted to SEK 304.9 (318.9) Operating profit amounted to SEK 36.4 M (79.3) Profit after tax amounted to SEK 30.8 M (61.4) Earnings per share before/after...
Related Questions
What are the primary drivers behind the significant drop in operating profit from SEK 79.3M to SEK 36.4M?
Are there any changes in the product mix or pricing that explain the revenue decrease?
Will the company provide guidance on future order intake and sales for Q3 and Q4 2025?
How does the current EPS after tax compare to analyst consensus estimates?
What is the impact of the lower earnings on the dividend policy and payout ratio?
How does RaySearch’s performance compare with its main competitors in the medical software market?
What are the expectations for the upcoming product launches or regulatory approvals that could offset the current downtrend?
What are the cash flow and liquidity implications of the reduced earnings?
How does the decline in order intake and net sales versus the prior period affect our revenue forecasts for the remainder of 2025?
Does management expect any cost‑cutting or restructuring measures to improve profitability?
How sensitive is the stock price likely to be to these earnings results given the -60 sentiment score?
What is the outlook for operating margins and how does it compare to the prior quarter?